<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The most common <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">pulmonary disorder</z:e> induced by <z:chebi fb="0" ids="44185">methotrexate</z:chebi> is a gradually developing <z:hpo ids='HP_0006515'>interstitial pneumonitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The associated clinical manifestations include <z:hpo ids='HP_0003677'>slowly progressive</z:hpo> <z:hpo ids='HP_0002094'>dyspnea</z:hpo> and nonproductive cough, with extensive radiographic changes </plain></SENT>
<SENT sid="2" pm="."><plain>One case has been reported following intrathecal <z:chebi fb="0" ids="44185">methotrexate</z:chebi> administration; the remainder occurred after either intravenous or oral therapy </plain></SENT>
<SENT sid="3" pm="."><plain>We report two cases of rapidly developing <z:hpo ids='HP_0002098'>respiratory distress</z:hpo> following the administration of <z:chebi fb="0" ids="44185">methotrexate</z:chebi> into the cerebrospinal fluid </plain></SENT>
<SENT sid="4" pm="."><plain>The clinical courses, radiologic findings, and, in one patient, the pathologic nature, are consistent with noncardiogenic <z:hpo ids='HP_0100598'>pulmonary edema</z:hpo> </plain></SENT>
</text></document>